B

Bionano Genomics
D

BNGO

5.36500
USD
0.02
(0.28%)
مغلق
حجم التداول
2,044
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
12,502,617
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    N
    NCSM
    0.630
    (2.25%)
    28.630 USD
    N
    NTRA
    -5.740
    (-3.41%)
    162.430 USD
    O
    OOMA
    -0.490
    (-3.28%)
    14.430 USD
    P
    PSTG
    -2.750
    (-4.05%)
    65.080 USD
    R
    RARE
    -1.920
    (-4.31%)
    42.590 USD
    R
    RGNX
    -0.08500
    (-1.15%)
    7.28000 USD
    V
    VEEV
    -2.960
    (-1.29%)
    225.900 USD
    المزيد
الأخبار
المقالات

العنوان: Bionano Genomics Inc

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.